ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > TLR8

TLR8

概要

Name:Toll like receptor 8
Target Synonym:UNQ249/PRO286,TLR8,Toll-like receptor 8,CD288,Toll Like Receptor 8,CD288 Antigen
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:12
Lastest Research Phase:Phase 2 Clinical

Product Inquiry

* We couldn't find what you're looking for. You can let us help by filling the form below. Our tech team will get back to you shortly.
* This form is only used to collect product demand consultation. All the information will be kept strictly confidential.
Product inquiry collection form
*
*
*
*
*
*
*
*
*
ACRO Quality

Synonym Name

TLR8/CD288/Toll-like receptor 8

Background

Toll-like receptors (TLRs) sense pathogen-associated molecular patterns originating from invading microorganisms and initiate innate immune responses. Toll-like receptors 8 and 7 (TLR8 and TLR7) are endosomal immune receptors and take a key role in innate and adaptive immunity. As a transmembrane receptor, TLR8 could recognize single-stranded RNA. Activation of TLR8 and TLR7 lead to immune cell stimulation and inflammatory cytokine production, which is normally a protective host response.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
VTX-1463 VTX-1463 Phase 1 Clinical Ventirx Rhinitis, Allergic Details
CB-06 CB 06036; CB-06 Phase 1 Clinical Shanghai Zhimeng Biopharma Inc Hepatitis B Details
Bazlitoran IMO-8400 Idera Details
HRS-9950 HRS-9950 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd, Shanghai Hengrui Pharmaceutical Co Ltd Hepatitis B, Chronic Details
BDC-1001 BDC-1001 Phase 2 Clinical Bolt Biotherapeutics Inc Solid tumours Details
CV-8102 CV-8102 Phase 1 Clinical Curevac Ag Squamous Cell Carcinoma of Head and Neck; Skin Neoplasms; Carcinoma, Adenoid Cystic; Rabies; Carcinoma, Squamous Cell; Carcinoma, Hepatocellular; Melanoma Details
Motolimod VTX-378; VTX-2337 Phase 1 Clinical Array Biopharma, Celgene Corp Salivary Gland Neoplasms; Tongue Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Endometrioid; Melanoma; Carcinoma, Squamous Cell; Lymphoma; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Fallopian Tube Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Breast Neoplasms; Cystadenocarcinoma; Carcinoma, Verrucous; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Squamous Cell Carcinoma of Head and Neck; Cystadenocarcinoma, Serous; Cystadenocarcinoma, Mucinous; Carcinoma, Renal Cell; Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours; Brenner Tumor Details
Enpatoran M-5049 Phase 2 Clinical Merck & Co Inc Lupus Erythematosus, Cutaneous; Coronavirus Disease 2019 (COVID-19); Lupus Erythematosus, Systemic Details
TransCon-TLR-7/8-agonist Phase 2 Clinical Ascendis Pharma Oncology Division As Solid tumours; Papillomavirus Infections; Neoplasm Metastasis Details
Afimetoran BMS-986256 Phase 2 Clinical Bristol-Myers Squibb Company Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic Details
E-6742 E-6742 Phase 2 Clinical Eisai Co Ltd Lupus Erythematosus, Systemic Details
DN-1508052 DN-1508052; DN1508052-01 Phase 2 Clinical Shanghai De Novo Pharmatech Co Ltd Solid tumours; Neoplasms Details
BDB-018 BDB-018 Phase 1 Clinical Seven And Eight Biopharmaceuticals Inc Solid tumours Details
Selgantolimod GS-9688 Phase 2 Clinical Gilead Inc HIV Infections; Hepatitis B, Chronic; Hepatitis B Details

This web search service is supported by Google Inc.

totopphone